• July 25, 2012
    VANCOUVER, British Columbia--Data to be presented this week at the 7th World Congress of Veterinary Dermatology (WCVD) Meeting 2012 will report new insights into the disease pathways involved in allergic conditions in dogs, Pfizer Animal Health announced today. Researchers with Pfizer Animal Health’s Global Therapeutic Research Group have, for the first time, identified a potential role for the cytokine IL-31 in triggering itchmore...
  • July 25, 2012
    VANCOUVER, British Columbia--Pfizer Animal Health will present data from discovery studies validating specific pathways of allergic skin disease in dogs and studies evaluating novel molecules targeting these pathways at the 7th World Congress of Veterinary Dermatology (WCVD) Meeting 2012 in Vancouver, British Columbia, from July 24–28. Approximately six presentations related to Pfizer’s research and development program in veterinary dermatologymore...
  • April 19, 2012
    PARIS, France--The famous Auzoux Horse, one of the first veterinary teaching aids of its kind, has been restored to its former glory thanks to a €50,000 grant from Pfizer Animal Health. The papier-mâché model dates back to 1846 and was initially created to allow veterinary students to mimic a dissection without having to use an actual cadaver, an unpleasant and dangerous choice in an era when it was not uncommon for people to die ofmore...
  • January 27, 2012
    Dozulé, Normandy, France--Pfizer Animal Health and The Hippolia Foundation announced today the formation of a strategic partnership to advance equine health through research and educational programmes. The Hippolia Foundation – a network of leading French equine institutions together with international partners – will collaborate with Pfizer to accelerate advancement in innovation on the diagnosis, treatment and prevention of equinemore...
  • November 8, 2011
    KALAMAZOO, Mich.--Pfizer Animal Health affirmed its commitment to innovation in equine health with the opening today of the Pfizer Animal Health Equine Research Center in Richland, Mich. The center, the culmination of a $7 million investment, expands Pfizer Animal Health’s global research and development network headquarters in Kalamazoo, Mich., and will serve as the worldwide hub for research and development of equine vaccines and novelmore...
  • October 13, 2011
    MADISON, N.J.--Five livestock veterinarians and about 20 of their client farms in four states volunteered to be filmed for a new reality series, to give consumers a personal and up-close view of responsible livestock farming in the U.S. The series, “Veterinarians on Call,” captures the pride and responsibility of veterinarians in their day-to-day work on U.S. farms and ranches, working with their client livestock farmers and othermore...
  • March 23, 2010
    NEW YORK--Because pet owners may be even more confused this spring about how to safely use topical flea-and-tick control treatments, Pfizer Animal Health is encouraging pet owners to consult with their veterinarian, instead of attempting to manage flea-and-tick control on their own. This month, the U.S. Environmental Protection Agency (EPA) announced new actions to increase the safety of dozens of spot-on pesticide products thatmore...
  • February 15, 2010
    LAS VEGAS--Pfizer Animal Health today announced that the U.S. Food and Drug Administration (FDA) has approved EXCEDE® Sterile Suspension as the first safe and effective, long-acting antibiotic formulation licensed for horses. EXCEDE Sterile Suspension is the newest addition to Pfizer Animal Health’s extensive portfolio of equine products backed by scientific research and innovation in the field of equine medicine. EXCEDE Sterilemore...